Published in Sci Rep on February 17, 2015
Is it time for immunopsychiatry in psychotic disorders? Psychopharmacology (Berl) (2016) 0.82
Gut Microbiota: The Brain Peacekeeper. Front Microbiol (2016) 0.81
Diverse action of lipoteichoic acid and lipopolysaccharide on neuroinflammation, blood-brain barrier disruption, and anxiety in mice. Brain Behav Immun (2016) 0.77
omicsNPC: Applying the Non-Parametric Combination Methodology to the Integrative Analysis of Heterogeneous Omics Data. PLoS One (2016) 0.75
Involvement of Host Defense Mechanisms against Toxoplasma gondii Infection in Anhedonic and Despair-Like Behaviors in Mice. Infect Immun (2017) 0.75
Postnatal TLR2 activation impairs learning and memory in adulthood. Brain Behav Immun (2015) 0.75
Cerebrovascular complications of diabetes: focus on cognitive dysfunction. Clin Sci (Lond) (2016) 0.75
Toll-Like Receptor 2 Is a Regulator of Circadian Active and Inactive State Consolidation in C57BL/6 Mice. Front Aging Neurosci (2017) 0.75
Cross Talk: The Microbiota and Neurodevelopmental Disorders. Front Neurosci (2017) 0.75
TLR2 Knockout Protects Against Diabetes-Mediated Changes in Cerebral Perfusion and Cognitive Deficits. Am J Physiol Regul Integr Comp Physiol (2017) 0.75
Pathogen recognition and innate immunity. Cell (2006) 44.14
Innate immune recognition. Annu Rev Immunol (2001) 26.65
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity (1999) 17.40
Biological insights from 108 schizophrenia-associated genetic loci. Nature (2014) 16.13
Schizophrenia. Lancet (2009) 8.14
Modelling schizophrenia using human induced pluripotent stem cells. Nature (2011) 7.41
Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus. Proc Natl Acad Sci U S A (2006) 5.83
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) (2001) 5.67
Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet (2004) 4.71
Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol (2007) 4.00
Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol (2000) 3.96
Neurobiology of schizophrenia. Neuron (2006) 3.69
Toll signaling pathways in the innate immune response. Curr Opin Immunol (2000) 3.37
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell (2013) 3.26
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry (2007) 3.22
Schizophrenia and violence: systematic review and meta-analysis. PLoS Med (2009) 2.74
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) (2008) 2.64
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A (2003) 2.62
Diverse psychotomimetics act through a common signaling pathway. Science (2003) 2.52
Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry (2009) 2.46
Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol Psychiatry (2006) 2.11
Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proc Natl Acad Sci U S A (2010) 2.05
Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci (2011) 2.01
GSK-3: Functional Insights from Cell Biology and Animal Models. Front Mol Neurosci (2011) 1.99
Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res (2005) 1.84
Selective engagement of plasticity mechanisms for motor memory storage. Neuron (2006) 1.82
Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond) (2011) 1.73
Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am J Psychiatry (2009) 1.71
Animal models of schizophrenia. Br J Pharmacol (2011) 1.60
Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J Neurosci (2008) 1.55
Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry (2001) 1.55
Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. EMBO J (2009) 1.30
Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin. Transl Psychiatry (2012) 1.26
The cerebellum and neuropsychological functioning: a critical review. J Clin Exp Neuropsychol (2011) 1.25
Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning. Cereb Cortex (2007) 1.24
Animal models for the negative symptoms of schizophrenia. Behav Pharmacol (2000) 1.22
Brain maturational processes and delayed onset in schizophrenia. Dev Psychopathol (1999) 1.17
Evidence for a dysregulated immune system in the etiology of psychiatric disorders. J Neuroimmune Pharmacol (2013) 1.17
Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol Ther (2011) 1.12
Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia. Curr Top Behav Neurosci (2010) 1.12
Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol (2002) 1.09
TLR2 activation inhibits embryonic neural progenitor cell proliferation. J Neurochem (2010) 0.99
Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Curr Top Behav Neurosci (2012) 0.97
Maternal immune activation alters behavior in adult offspring, with subtle changes in the cortical transcriptome and epigenome. Schizophr Res (2012) 0.97
Evidence for a developmental role for TLR4 in learning and memory. PLoS One (2012) 0.94
Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia. Schizophr Bull (2009) 0.93
Behavioral indices in antipsychotic drug discovery. J Pharmacol Exp Ther (2010) 0.92
Protein Phosphatase 2a and glycogen synthase kinase 3 signaling modulate prepulse inhibition of the acoustic startle response by altering cortical M-Type potassium channel activity. J Neurosci (2010) 0.91
Motor deficits in schizophrenia quantified by nonlinear analysis of postural sway. PLoS One (2012) 0.89
The multidimensionality of schizotypy in nonpsychotic relatives of patients with schizophrenia and its applications in ordered subsets linkage analysis of schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2010) 0.88
Neural stem cell grafting counteracts hippocampal injury-mediated impairments in mood, memory, and neurogenesis. Stem Cells Transl Med (2012) 0.86
Impaired monocyte activation in schizophrenia. Psychiatry Res (2012) 0.86
Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.86
Regulation of hippocampal long-term potentiation and long-term depression by diacylglycerol kinase ζ. Hippocampus (2010) 0.82
Association between genetic polymorphisms of Toll-like receptor 2 (TLR2) and schizophrenia in the Korean population. Gene (2013) 0.81
Transient receptor potential canonical channels regulate the induction of cerebellar long-term depression. J Neurosci (2012) 0.80
Nocturnal hyperactivity, increased social novelty preference and delayed extinction of fear responses in post-weaning socially isolated mice. Brain Res Bull (2011) 0.80
The effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL/6 and APPswe/PS1dE9 mice. Behav Brain Res (2011) 0.80
A sensitive period for GABAergic interneurons in the dentate gyrus in modulating sensorimotor gating. J Neurosci (2013) 0.80
Ethanolic Extract of the Seed of Zizyphus jujuba var. spinosa Ameliorates Cognitive Impairment Induced by Cholinergic Blockade in Mice. Biomol Ther (Seoul) (2013) 0.78
An MRI atlas of the mouse basal ganglia. Brain Struct Funct (2013) 0.78
The ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in mice. Arch Pharm Res (2013) 0.76